AIToday

Dividend ETF outpaces Nasdaq-100 in 2026 with 3.2% yield

Yahoo Finance AI3h ago
Dividend ETF outpaces Nasdaq-100 in 2026 with 3.2% yield

Key takeaway

The Schwab U.S. Dividend Equity ETF has delivered a rare win for dividend investors in 2026, returning about 20% and outpacing the Nasdaq-100's 17% gain by screening for 100 high-quality dividend payers with at least 10 consecutive years of dividend history. The fund's concentration in healthcare, consumer staples, and energy—and its exclusion of expensive AI and software names like Nvidia, Microsoft, and Alphabet—has paid off as the market rotates toward steadier earners, though longer-term the growth indexes have still pulled ahead.

Summaries like this, in your inbox every morning.

Sign up free →

3 Key Points

  • What happened

    The Schwab U.S. Dividend Equity ETF (SCHD) has returned about 20% in 2026 as of publication, beating both the S&P 500's roughly 11% gain and the Nasdaq-100's roughly 17% return. The $95 billion(約15兆円) fund yields about 3.2% and charges just 0.06% in annual expenses.

  • Why it matters

    The fund's outperformance reflects a market rotation away from expensive software and AI names toward steadier dividend payers in healthcare, consumer staples, and energy—sectors the fund was already concentrated in. Investors seeking stable income and lower valuations (the fund trades at about 17 times earnings versus the mid-20s for an S&P 500 index fund) are finding both here, without exposure to the AI trade's volatility.

  • What to watch

    Over the past 12 months the Nasdaq-100 has still returned about 30%, ahead of this fund's 27%, and the article notes that if AI stocks reassert themselves in the second half of the year, the performance order could flip back. The fund distributes income quarterly and has compounded at about 13% a year since its launch more than a decade ago.

In Depth

The Schwab U.S. Dividend Equity ETF is a $95 billion(約15兆円) fund that has returned about 20% in 2026 as of publication, outpacing both the S&P 500's roughly 11% gain and the Nasdaq-100's roughly 17% return. The fund yields about 3.2% and charges just 0.06% in annual expenses, making it an unusually strong performer for a conservative income fund at a time when growth-focused indexes have dominated market returns throughout the AI boom.

The fund's success stems from its rigorous selection methodology. It tracks the Dow Jones U.S. Dividend 100 Index, which limits membership to companies that have paid dividends for at least 10 consecutive years and excludes real estate investment trusts and master limited partnerships entirely. From that pool, the index evaluates the highest-yielding candidates on four fundamentals: free cash flow relative to total debt, return on equity, dividend yield, and five-year dividend growth. The top 100 companies make the cut, subject to concentration limits—no single stock can exceed 4% of the index at rebalance, and no sector can exceed 25%. The index is reviewed annually and rebalanced quarterly. These quality screens are intended to identify sustainable payers and avoid yield traps, companies whose fat dividends signal deteriorating finances.

The resulting portfolio looks fundamentally different from growth-focused benchmarks. The biggest holdings are UnitedHealth Group, Home Depot, and Abbott Laboratories, each at about 4.3% to 4.5% of assets, alongside dividend stalwarts like Coca-Cola, Procter & Gamble, and Chevron. Healthcare comprises about 21% of the portfolio and consumer staples another 21%. Notably absent are the market's dominant AI names: Nvidia, Microsoft, and Alphabet do not appear in the fund's top 25 holdings because their tiny yields or short dividend histories do not meet the index's criteria.

In 2026, this exclusion has become an advantage. Many of the market's most expensive software and AI names have struggled, prompting investors to rotate toward steadier earners in drugmakers, household staples, and energy—the very sectors in which the fund was already concentrated. The fund trades at about 17 times its holdings' earnings, versus the mid-20s for an S&P 500 index fund, meaning investors are purchasing a cheaper collection of businesses while being paid more to hold it. The fund has distributed $1.05 per share over the past 12 months, yielding about 3.2% at the current price.

However, the article cautions against extrapolating from this single year. Over the past 12 months the Nasdaq-100 has returned about 30%, still ahead of the fund's 27% return, indicating that growth stocks remain ahead in the longer race. If AI stocks reassert themselves in the second half of the year, the performance order could flip right back. The fund's core purpose is to deliver a growing income stream from durable businesses with less volatility than growth indexes—a job it has performed well, compounding at about 13% a year since its launch more than a decade ago. For investors seeking income and an anchor that does not depend on the AI trade remaining hot, the article suggests the fund remains a solid buy even near its 52-week high.

Context & Analysis

The Schwab U.S. Dividend Equity ETF's 2026 outperformance represents an unusual inflection in a market long dominated by growth stocks. For most of the artificial intelligence boom, investors have viewed dividend stocks as a conservative holding for stability, while growth indexes set the market's pace. This year, however, the rotation has shifted: many of the market's most expensive software and AI names have struggled, and investors have rotated toward steadier earners in healthcare, consumer staples, and energy. The fund was already positioned in exactly these sectors, making its concentration a strategic advantage rather than a drag.

The fund's selection rules reinforce this positioning by design. Companies must have paid dividends for at least 10 consecutive years, and the index evaluates candidates on free cash flow relative to debt, return on equity, dividend yield, and five-year dividend growth. These screens are designed to avoid yield traps—high dividends that signal deteriorating businesses—and ensure the fund holds companies capable of sustaining payouts. The result is a portfolio trading at about 17 times earnings, versus the mid-20s for an S&P 500 index fund, offering investors cheaper valuations alongside a 3.2% yield and just 0.06% in annual expenses.

However, the article cautions against drawing a permanent conclusion from one year's performance. Over the past 12 months the Nasdaq-100 has still returned about 30%, ahead of this fund's 27%, indicating that growth stocks remain ahead in the longer race. If AI and software stocks reassert themselves later in 2026, the performance order could reverse. The fund's stated job is to deliver a growing income stream from durable businesses with less volatility, not to outrun the Nasdaq-100—and on that measure it has compounded at about 13% a year since its launch more than a decade ago.

FAQ

What are the main holdings in this ETF?
The biggest holdings are UnitedHealth Group, Home Depot, and Abbott Laboratories, each at about 4.3% to 4.5% of assets, alongside names like Coca-Cola, Procter & Gamble, and Chevron. Healthcare makes up about 21% of the portfolio, and consumer staples another 21%.
Why doesn't the fund hold major AI companies like Nvidia or Microsoft?
The fund tracks the Dow Jones U.S. Dividend 100 Index, which requires companies to have paid dividends for at least 10 consecutive years. Market-dominant AI names with tiny yields or short dividend histories do not come close to qualifying.
How much income does the fund distribute?
The fund has distributed $1.05 per share over the past 12 months, and at the current price it yields about 3.2%.

Get AI news like this every morning

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytime

Discussion

No discussion yet for this article

Stay ahead with AI news

Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.

Get Started Free

Free · takes 30 seconds · unsubscribe anytime

1 minute a day. The AI essentials.

200+ sources · Email / LINE / Slack

Get it free →